Agenus Investor Relations Material
Latest events
Q1 2025
Agenus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Agenus Inc
Access all reports
Agenus Inc. is a biotechnology company focused on the discovery and development of immunotherapies for cancer and other diseases. The company specializes in antibody-based therapies, including immune checkpoint inhibitors and personalized cancer vaccines. Agenus leverages its proprietary research platforms to develop novel treatments that enhance the body's immune response against tumors. Agenus Inc. is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
AGEN
Country
🇺🇸 United States